[Federal Register: March 28, 2008 (Volume 73, Number 61)]
[Notices]
[Page 16684-16685]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28mr08-84]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Program Office on Vaccine
Financing
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (DHHS) is hereby
giving notice that the National Vaccine Program Office (NVPO) will
convene a meeting of the Vaccine Finance Working Group and is inviting
input from stakeholders on this issue. The meeting will be open to the
public.
DATES: The meeting will be held on Tuesday, April 29, 2008 and
Wednesday, April 30, 2008. The meeting will be held from 9 a.m. to 5
p.m. on both days.
ADDRESSES: Hilton Washington DC/Rockville Hotel and Executive Meeting
Center; 1750 Rockville Pike, Rockville, MD 20852-1699.
FOR FURTHER INFORMATION CONTACT: Angela Shen, National Vaccine Program
Office, Department of Health and Human Services, Room 443-H, Hubert H.
Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201;
(202) 260-1587, or e-mail angela.shen@hhs.gov.
SUPPLEMENTARY INFORMATION: NVPO has responsibility for coordinating and
ensuring collaboration among the many Federal agencies involved in
vaccine and immunization activities. The NVPO provides leadership and
coordination among Federal agencies, as they work together to carry out
the goals of the National Vaccine Plan. The National Vaccine Plan
provides a framework, including goals, objectives, and strategies, for
pursuing the prevention of infectious diseases through immunizations.
NVPO periodically convenes working groups to address specific issues
and topics that impact vaccine and immunization.
The Vaccine Finance Working Group was established to address issues
related to vaccine financing in the United States. The Working Group
has developed a draft white paper with a number of policy options to be
considered for presentation to the National Vaccine Advisory Committee
(NVAC) for discussion. NVPO has charged the Vaccine Finance Working
Group to obtain input from stakeholders whose viewpoints and interests
can help shape an understanding of the issues that are relevant to the
challenges in creating optimal approaches to vaccine financing in both
the public and private sectors.
The two-day meeting is scheduled to be held to provide an
opportunity for vaccine financing stakeholders to discuss and make
comments on the draft white paper and to solicit input, in particular,
regarding the conclusions and options made by the working group that
are contained in the draft document. A wide range of stakeholders
representing health care providers, employers, payers, health insurers,
vaccine manufacturers and distributors, consumers, and other interested
parties within the public health community are invited to attend the
meeting. Members of the public will have the opportunity to provide
comments at the meeting. Public comment will be limited to five minutes
per speaker. Any members of the public who wish to have printed
material distributed to meeting
[[Page 16685]]
participants should submit materials to the NVPO staff person
designated as the contact for additional information. All materials
should be submitted to the designated point of contact no later than
close of business April 21, 2008. Pre-registration is required for
public comment. Any individual who wishes to participate in the public
comment session should e-mail angela.shen@hhs.gov or call 202-690-5566.
There is limited space available for the public to attend this
meeting. However, it is desired that the public participate in the
discussions, as well. Registration is required to attend the meeting;
registration information can be found at: https://
nvpo.constellagroup.com. Registration for the meeting will be accepted
until April 5, 2008. Registration after that date will be on the basis
of space availability. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the designated contact person.
Dated: March 24, 2008.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E8-6433 Filed 3-27-08; 8:45 am]
BILLING CODE 4150-44-P